未登录Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry免疫组织化学在HER2-Positive和模棱两可的乳腺癌中的遗传改变
Tsai, Yi-Fang; Hsu, Chih-Yi; Chiu, Yun-Ning; Huang, Chi-Cheng; Chou, Shih-Hsiang; Lin, Yen-Shu; Chao, Ta-Chung; Liu, Chun-Yu; Chiu, Jen-Hwey; Tseng, Ling-Ming
分享
收藏Role of ITGB2 in patients with luminal B1 breast cancer
Liu, Chun-Yu; Chen, Ji-Lin; Tsai, Yi-Fang; Chao, Ta-Chung; Wang, Wan-Lun; Lien, Pei-Ju; Hsu, Chih-Yi; Lai, Jiun-I; Huang, Chi-Cheng; Chiu, Jen-Hwey; Tseng, Ling-Ming
分享
收藏Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
Cheng, Han-Fang; Tsai, Yi-Fang; Liu, Chun-Yu; Hsu, Chih-Yi; Lien, Pei-Ju; Lin, Yen-Shu; Chao, Ta-Chung; Lai, Jiun-I.; Feng, Chin-Jung; Chen, Yen-Jen; Chen, Bo-Fang; Chiu, Jen-Hwey; Tseng, Ling-Ming; Huang, Chi-Cheng
分享
收藏
分享
收藏
分享
收藏Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers台湾乳腺癌中同源重组修复基因的肿瘤基因组改变的患病率
Huang, Chi-Cheng; Tsai, Yi-Fang; Liu, Chun-Yu; Lien, Pei-Ju; Lin, Yen-Shu; Chao, Ta-Chung; Feng, Chin-Jung; Chen, Yen-Jen; Lai, Jiun-, I; Phan, Nam Nhut; Hsu, Chih-Yi; Chiu, Jen-Hwey; Tseng, Ling-Ming
分享
收藏VGH-TAYLOR: Comprehensive precision medicine study protocol on the heterogeneity of Taiwanese breast cancer patients
Liu, Chun-Yu; Huang, Chi-Cheng; Tsai, Yi-Fang; Chao, Ta-Chung; Lien, Pei-Ju; Lin, Yen-Shu; Feng, Chin-Jung; Chen, Ji-Lin; Chen, Yen-Jen; Chiu, Jen-Hwey; Hsu, Chih-Yi; Tseng, Ling-Ming
分享
收藏
分享
收藏Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses
Huang, Chi-Cheng; Tsai, Yi-Fang; Liu, Chun-Yu; Chao, Ta-Chung; Lien, Pei-Ju; Lin, Yen-Shu; Feng, Chin-Jung; Chiu, Jen-Hwey; Hsu, Chih-Yi; Tseng, Ling-Ming
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancerHER2免疫组织化学评分为HER2-type浸润性乳腺癌患者提供预后信息
Tsai, Yi-Fang; Tseng, Ling-Ming; Lien, Pei-Ju; Hsu, Chih-Yi; Lin, Yen-Shu; King, Kuang-Liang; Wang, Yu-Ling; Chao, Ta-Chung; Liu, Chun-Yu; Chiu, Jen-Hwey; Yang, Muh-Hwa
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏